These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4944951)

  • 41. [In vivo antibacterial activity of an antibiotic association and its components].
    Bernardi F; Liani M; Ricci P
    Antibiotica; 1969 Dec; 7(4):269-74. PubMed ID: 5407462
    [No Abstract]   [Full Text] [Related]  

  • 42. Thiolactomycin-Based Inhibitors of Bacterial β-Ketoacyl-ACP Synthases with in Vivo Activity.
    Bommineni GR; Kapilashrami K; Cummings JE; Lu Y; Knudson SE; Gu C; Walker SG; Slayden RA; Tonge PJ
    J Med Chem; 2016 Jun; 59(11):5377-90. PubMed ID: 27187871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aminophylline-induced suppression of pulmonary antibacterial defenses.
    Nelson S; Summer WR; Jakab GJ
    Am Rev Respir Dis; 1985 Jun; 131(6):923-7. PubMed ID: 3890643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antibacterial effect of rifampicin and its chemotherapeutic properties in experiments on animals].
    Shorin VA; Shapovalova SP; Malkova IV
    Antibiotiki; 1974 Dec; 19(12):1084-8. PubMed ID: 4155605
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection.
    Bakker-Woudenberg IA; ten Kate MT; Goessens WH; Mouton JW
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2919-25. PubMed ID: 16940082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009.
    Mohammadtaheri Z; Pourpaki M; Mohammadi F; Namdar R; Masjedi MR
    Chemotherapy; 2010; 56(6):478-84. PubMed ID: 21099220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
    Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
    Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The serum concentration of bactericidal antibiotics (rifampicin, cephaloridine) in relation to the low resistance period in experimental infections. Immunological investigations in experimental chemotherapy. V.
    Sackmann W
    Chemotherapy; 1971; 16(3):203-10. PubMed ID: 4397820
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of hypoxic stress on survival times of mice infected with either Staphylococcus aureus or Klebsiella pneumoniae.
    Walker RI; New AE; Wang WC
    Southeast Asian J Trop Med Public Health; 1974 Jun; 5(2):190-6. PubMed ID: 4606506
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro and in vivo activities of ciprofloxacin and levofloxacin against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
    Szabó D; Máthé A; Lengyel J; Anderlik P; Rókusz L; Rozgonyi F
    Curr Med Chem; 2002 Feb; 9(4):437-42. PubMed ID: 11945119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antiseptic effect of compound lysostaphin disinfectant and its preventive effect on infection of artificial dermis after graft on full-thickness skin defect wound in rats].
    Jin J; Zhou H; Cui ZC; Wang L; Luo PF; Ji SZ; Hu XY; Ma B; Wang GY; Zhu SH; Xia ZF
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):225-232. PubMed ID: 29690741
    [No Abstract]   [Full Text] [Related]  

  • 52. Prekallikrein - an emerging therapeutic target for Klebsiella pneumoniae infection?
    Lam Z; Condliffe AM
    J Pathol; 2020 Apr; 250(4):359-361. PubMed ID: 31943204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase.
    Aratani Y; Kura F; Watanabe H; Akagawa H; Takano Y; Suzuki K; Maeda N; Koyama H
    J Infect Dis; 2000 Oct; 182(4):1276-9. PubMed ID: 10979934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of cefoperazone sodium in the treatment of infected bronchiectasis in the aged].
    Pendenza E; Rossi G; Pendenza L
    G Clin Med; 1988 Oct; 69(10):621-2. PubMed ID: 3068092
    [No Abstract]   [Full Text] [Related]  

  • 55. Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.
    Schiffelers RM; Storm G; ten Kate MT; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2001 Feb; 45(2):464-70. PubMed ID: 11158742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of arsenic trioxide inhalation exposure on pulmonary antibacterial defenses in mice.
    Aranyi C; Bradof JN; O'Shea WJ; Graham JA; Miller FJ
    J Toxicol Environ Health; 1985; 15(1):163-72. PubMed ID: 3884825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A clinical study of primary infection on the lungs and pleura by Friedlander's bacillus.
    Narang RK; Kansal HM; Gupta RK
    Indian J Chest Dis Allied Sci; 1976 Jan; 18(1):43-50. PubMed ID: 773813
    [No Abstract]   [Full Text] [Related]  

  • 58. The role of C-type lectins in the innate immunity against pulmonary pathogens.
    Ofek I; Crouch E; Keisari Y
    Adv Exp Med Biol; 2000; 479():27-36. PubMed ID: 10897407
    [No Abstract]   [Full Text] [Related]  

  • 59. Sulphenazone sensitivity of some pathogens, and its effect in diseases of the upper respiratory tract.
    Korányi G; Pesti E; Somogyi G
    Acta Paediatr Acad Sci Hung; 1972; 13(3):225-30. PubMed ID: 4631517
    [No Abstract]   [Full Text] [Related]  

  • 60. Anti-inflammatory effects of inhaled nitric oxide are optimized at lower oxygen concentration in experimental Klebsiella pneumoniae pneumonia.
    Sun Z; Sun B; Wang X; Wang W; Zhu L
    Inflamm Res; 2006 Oct; 55(10):430-40. PubMed ID: 17109070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.